Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolution of conjugate vaccines.

P Helena Mäkelä1, Helena Käyhty

  • 1National Public Health Institute, Helsinki, Finland. Helena.Makela@ktl.fi

Expert Review of Vaccines
|August 7, 2003
PubMed
Summary

Conjugate vaccines, which link bacterial polysaccharides to proteins, have dramatically reduced diseases like Haemophilus influenzae type b. These vaccines induce immunologic memory, curb infection spread, and are increasingly vital globally.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Coadministered pneumococcal conjugate vaccine decreases immune response to hepatitis A vaccine: a randomized controlled trial.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2023
Same author

A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients.

Vaccine·2021
Same author

A randomized, controlled trial comparing the immunogenecity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients.

Transplant infectious disease : an official journal of the Transplantation Society·2020
Same author

Antibody response to the 23-valent pneumococcal polysaccharide vaccine after conjugate vaccine in patients with chronic lymphocytic leukemia.

Human vaccines & immunotherapeutics·2019
Same author

Comparison of serological assays using pneumococcal proteins or polysaccharides for detection of Streptococcus pneumoniae infection in children with community-acquired pneumonia.

Journal of immunological methods·2018
Same author

Antibody responses against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in children with acute respiratory infection with or without nasopharyngeal bacterial carriage.

Infectious diseases (London, England)·2018

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • Conjugate vaccines represent a significant advancement in vaccinology, improving immunogenicity of bacterial polysaccharides.
  • Their introduction less than 20 years ago has led to remarkable public health successes.
  • Key examples include vaccines against Haemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis.

Purpose of the Study:

  • To review the success and impact of conjugate vaccines.
  • To highlight the mechanisms behind their efficacy, such as inducing immunologic memory and reducing carriage.
  • To discuss current considerations regarding their global use, including efficacy and cost-effectiveness.

Main Methods:

  • Review of existing literature and public health data on conjugate vaccine impact.
  • Analysis of the immunological principles underlying conjugate vaccine effectiveness.
  • Examination of epidemiological data and economic evaluations.

Main Results:

  • The Haemophilus influenzae type b conjugate vaccine has drastically reduced invasive disease globally.
  • Conjugate vaccines effectively induce immunologic memory and reduce asymptomatic carriage, limiting pathogen transmission.
  • Pneumococcal and meningococcal conjugate vaccines have been successfully implemented in major public health programs.

Conclusions:

  • Conjugate vaccines are a highly successful vaccine platform with profound public health benefits.
  • Their ability to establish long-term immunity and reduce transmission makes them critical tools in infectious disease control.
  • Ongoing evaluation of efficacy and cost-effectiveness is essential for optimizing global deployment.

Related Experiment Videos